14.7: The Adaptive Immune Response

Essentials of Physiology for Nurse Anesthetists (Gopalan) · LibreTexts

0%

Contents

    Text

    Size
    100%
    Theme
    Typeface
    Line length
    Spacing

    Read aloud

    How

    Speed: 1×
    Light up
    Highlight

    Symbols: Mulberry Symbols, © 2018–2026 Steve Lee, CC BY-SA 4.0 (licence, the set), the site's own copies.

    From LibreTexts, under CC BY-NC-SA, as the source states it; its equations are written in TeX, which the PDF shows typeset. This page at LibreTexts.

    14.7: The Adaptive Immune Response

    Innate immunity serves as the body's initial line of defense, offering quick, non-specific protection against pathogens. In contrast, adaptive immunity is more targeted and slower to develop but provides long-lasting protection and memory against specific pathogens (Table 4). Together, these systems work in harmony to ensure comprehensive defense against infections. While innate responses may not entirely stop pathogen growth, they slow it down, allowing the adaptive immune system to strengthen and effectively combat the infection. Within adaptive immunity, responses can be divided into antibody-mediated (humoral) responses led by B cells and cell-mediated responses driven by T cells.

    The adaptive immune response is distinguished by its remarkable specificity, allowing it to accurately identify and defend against a vast array of pathogens. This specificity is achieved through receptors on B and T lymphocytes, which can recognize unique antigens. The immune system can generate up to 100 trillion distinct receptors, enabling it to respond to nearly any pathogen. Insights into how the immune system encodes such a diverse array of antibodies and T cell specificities were made possible by advancements in molecular genetics during the 1970s and 1980s.

    The first encounter between the immune system and a pathogen is termed the primary response. This response tends to be severe as the adaptive immune system takes time to mount an effective defense. In contrast, upon re-exposure to the same pathogen, the secondary response occurs, characterized by enhanced speed and strength, often neutralizing the pathogen before it can cause significant damage or symptoms. This rapid response is the basis of immunological memory, which provides lasting protection against recurrent infections. 

    A key feature of the adaptive immune response is its ability to distinguish between self-antigens, which are present in the body, and foreign antigens associated with potential pathogens. Protective mechanisms during the maturation of T and B cells help prevent them from targeting self-antigens, thus avoiding harmful immune reactions. However, these mechanisms can fail, leading to autoimmune diseases.1

    Table 4 | Comparison of Innate and Adaptive Immunity |
    Innate (natural or native) Adaptive (acquired)
    Nonspecific Specific
    Immediate protection Develops slowly
    Limited ability More effective
    Ancient defense system Recently evolved
    Present in invertebrates and vertebrates Seen only in vertebrates
    Responds in the same way to repeat encounters Responds more efficiently to each successive encounter

    Cell-Mediated Immune Responses

    The primary orchestrators of the adaptive immune response are lymphocytes, including T and B cells. T cells are particularly crucial as they directly regulate various immune reactions and often influence B cell activity. As a result, many decisions regarding how to combat pathogens are made at the T cell level.

    T Cell Receptor

    The T cell receptor consists of two chains, each containing two domains (Figure 12). The variable region domain, located furthest from the T cell membrane, is named for its variability in amino acid sequences among receptors. In contrast, the constant region domain shows less variation. The differences in the variable domains provide the molecular basis for the receptor's ability to recognize a wide range of antigens. The antigen-binding site is formed at the terminal ends of both chains, with the sequences here determining the receptor's specificity. Each T cell produces only one type of receptor, making it specific to a particular antigen.1

    image28.jpg

    Figure 12 | T Cell Receptor | 15  T cell receptors (TCRs) are heterodimeric membrane-bound proteins composed of α and β chains. The antigen-binding site is located in the variable domain of each chain. A constant region links the two chains and contributes to structural stability. The transmembrane region anchors the TCR to the cell surface.

    Antigens

    Pathogens often display complex antigens that contain numerous antigenic determinants, or epitopes, which are the specific regions where receptors can bind (Figure 13). These determinants are usually small, comprising six or fewer amino acid residues in protein antigens or one to two sugar units in carbohydrate antigens. Protein antigens are complex molecules that can adopt a variety of three-dimensional shapes, which are crucial for eliciting immune responses against viruses and parasitic worms. The specificity of this immune response arises from the interaction between the shape of the antigen and the complementary configuration of amino acids within the antigen-binding site of immune receptors. This precise fit forms the fundamental chemical basis for the specificity observed in immune reactions. Carbohydrate epitopes tend to have less variability compared to protein ones. Such carbohydrate determinants are frequently found on bacterial cell walls and on red blood cell surfaces, as seen with the ABO blood group antigens.1

    image21.jpg

    Figure 13 | Antigenic Determinants | 16  T cell receptors (TCRs) vary in shape and amino acid sequence, allowing them to bind with high affinity to specific antigenic determinants. The figure shows three distinct TCRs recognizing different regions of the same protein antigen.

    Antigen Processing and Presentation

    T cells recognize antigens through specialized cells known as antigen-presenting cells (APCs) rather than directly engaging with free-floating antigens. APCs internalize antigens and process them into smaller fragments through enzymatic cleavage. These fragments are then displayed on the cell surface bound to MHC molecules. This process, known as antigen presentation, allows T cells to identify the antigen-MHC complex ( Figure 14).

    image24.jpg

    Figure 14 | Antigen Processing and Presentation | 17 Antigen-presenting cells (APCs) engulf extracellular pathogens into vesicles, where lysosomal digestive enzymes break them down. The resulting antigen from the digested pathogen binds within the peptide-binding cleft of MHC class II molecules (green pathway) and is displayed on the cell surface. Intracellular pathogens are processed in the cytosol and loaded onto MHC class I molecules (orange pathway). Both pathways lead to the presentation of antigen-MHC complexes (red pathway), which are recognized by a T cell receptor on a T cell, initiating an immune response.

    MHC molecules, MHC class I and MHC class II, play essential roles in antigen presentation. Although they have different genetic origins, both classes transport processed antigens to the cell surface for T cell recognition. Antigens from various pathogens utilize specific MHC classes and follow distinct intracellular pathways before being displayed. The core mechanism involves enzymatic digestion of antigens, entry into the endomembrane system, and eventual expression on the APC surface for T cell interaction.

    Intracellular antigens, typically linked to viruses replicating within host cells and some intracellular parasites or bacteria, are processed in the cytosol. They are then transported to the endoplasmic reticulum, where they bind with MHC class I molecules and are subsequently displayed on the cell surface through transport vesicles. In contrast, extracellular antigens—common to many bacteria, parasites, and fungi—are taken up by receptor-mediated endocytosis into the cell's endomembrane system. Here, they merge with vesicles from the Golgi complex containing MHC class II molecules, enabling the antigen-MHC complex to be presented on the cell surface (Figure 14).

    Antigen-presenting Cells

    MHC Class I molecules are expressed by virtually all nucleated cells in the body, serving a vital role in immune surveillance. They present endogenous antigens—peptides derived from proteins synthesized within the cell, particularly those from viral infections or malignancies—to activate cytotoxic T cells. This mechanism is critical for the body's defense, as it allows CD8+ T cells to identify and eliminate infected cells across nearly all tissues. If cells lacked MHC Class I, they would be unable to trigger this essential T cell response. The high degree of polymorphism in MHC Class I genes means these molecules are unique to every individual (except identical twins), thus posing a major hurdle in tissue transplantation.  In contrast, class II MHC molecules are found exclusively on "professional" antigen-presenting cells (APCs) like macrophages, dendritic cells, and B cells, which support broader immune functions. Macrophages release cytokines to boost phagocytosis, while dendritic cells transport antigens to lymph nodes, where T cell responses are initiated. B cells also present antigens to T cells, aiding specific antibody responses.1

    Table 5 | Cells Expressing MHC Class I and II Markers |
    MHC Cell type Phagocytic Function
    Class I All nucleated cells No Stimulates cytotoxic T cell immune response
    Class II Macrophage Yes Stimulates phagocytosis and presentation at primary infection site
    Class II Dendritic Yes Brings antigens to regional lymph nodes
    Class II B cell Yes Internalizes surface Ig and antigen. Stimulates antibody secretion by B cells

    T Cell Development and Differentiation

    The process by which T cells that could potentially attack the body's own cells are removed is called T cell tolerance. Thymocytes start as double-negative cells in the thymic cortex, meaning they lack CD4 and CD8 molecules. Here, they undergo positive selection, interacting with MHC molecules on cortical epithelial cells to ensure recognition of self MHC molecules. Most thymocytes are eliminated during differentiation, with only around 2 percent surviving to become mature T cells. As they mature, thymocytes express both CD4 and CD8 markers and become double-positive. They then migrate to the cortico-medullary junction, where they undergo negative selection, encountering self-antigens from throughout the body. Thymocytes that bind strongly to these self-antigens are eliminated via apoptosis. Those that survive negative selection develop into single-positive T cells- CD4+ cells, which interact with class II MHC, or CD8+ cells, which interact with class I MHC (Figure 15).1

    image11.jpg

    Figure 15 | Differentiation of T Cells within the Thymus | 18 Undifferentiated double negative thymocytes from the bone marrow migrate to the thymus. In the cortex, they mature into double-positive (DP) thymocytes after expressing various receptors. These cells undergo positive selection, where only those with moderate binding of immature thymocyte receptors to MHC molecules survive. Thymocytes that fail to bind appropriately undergo apoptosis. The surviving DP cells then travel to the medulla for negative selection, where those with strong binding of either CD4 or CD8 receptor to self-antigens are eliminated. The remaining self-tolerant thymocytes mature into single-positive (SP) cells, either expressing CD8+ or CD4+ and developing into T helper cells or T cytotoxic cells respectively. These cells are then released to the lymphatic system.

    T Cell Types and their Functions

    T cells are crucial in directly combating pathogens and orchestrating the adaptive immune response. They can be classified into various types based on distinctive surface markers, target cells, and the specific pathogens they interact with. This classification reflects their diverse functions in the immune system, as detailed in Table 6. Each T cell type contributes uniquely to immune modulation and pathogen elimination. 

    Mature T cells express either the CD4 or CD8 marker exclusively. These markers bind to regions on the MHC molecule separate from the antigen-binding site, enabling T cells to establish two key connections: CD4 or CD8 with the MHC molecule, and the T cell receptor with the antigen. CD4+ T cells perform helper functions, while CD8+ T cells are associated with cytotoxic activities (Figure 16). 

    Helper T Cells 

    Helper T cells, known as Th cells and identified by the CD4 molecule, are crucial in enhancing immune responses through cytokine release (Figure 17). These cells differentiate into distinct classes based not on surface markers but on the specific cytokines they produce. Th1 cells secrete cytokines that regulate immune activity and support the development of cells like macrophages and other T cells. In contrast, Th2 cells primarily aid B cells, stimulating their differentiation into plasma cells for antibody production—essential for antibody responses to most protein antigens.

    Cytotoxic T cells

    Cytotoxic T cells, or Tc cells, specialize in eliminating infected or cancerous target cells through apoptosis. They use two primary mechanisms: expressing the Fas ligand, which binds to the Fas receptor on the target cell, and releasing perforins and granzymes from their cytoplasmic granules (Figures 18 and 19). During an immune response, the proliferation of Tc cells significantly enhances their numbers, effectively limiting the virus's capacity to cause disease. Notably, each Tc cell can destroy multiple target cells.

    Regulatory T Cells

    Regulatory T cells, or Tregs, are a recently recognized subset of T cells characterized by the expression of the CD4 marker along with CD25 and FOXP3. They play a critical role in modulating immune responses by regulating the activity of other T cells. This function is vital in preventing excessive clonal expansion during immune responses, which can lead to autoimmune diseases and other health complications.1

    Table 6 | Functions of T Cell Types and Their Cytokines |
    T cell Target Function Pathogen Surface Marker MHC Cytokines or mediators
    Tc Infected cells Cytotoxicity Intracellular CD8 Class I Perforins, granzymes, and fas ligand
    Th1 Macrophage Helper inducer Extracellular CD4 Class II Interferon-γ and TGF-β
    Th2 B cell Helper inducer Extracellular CD4 Class II IL-4, IL-6, IL-10, and others
    Tregs Th cell Suppressor None CD4, CD25 ? TGF-β and IL-10

    T Cell Activation

    Mature T cells become activated upon recognizing antigens presented with self-MHC molecules. This triggers rapid mitotic division, a process known as clonal expansion. Only T cells with receptors specific to the antigen are activated. Once activated, these T cell clones rapidly expand, producing numerous copies equipped with the same receptor specificity. This process begins with stem cells differentiating into T cells, which then mature in the thymus before contributing to the adaptive immune response. During a primary adaptive immune response, the immune system produces two essential types of T cells: effector T cells and memory T cells. Effector T cells work to neutralize threats, release cytokines to modulate immune responses, and provide immediate defense against infections. They are short-lived compared to memory T cells. Memory T cells are long-lasting, remaining in the body for many years, often for a lifetime. These cells are ready for rapid deployment, ensuring that if the same pathogen is encountered again, the T cell response is quick and effective. This rapid secondary response results in a significant increase in effector T cells, which can eliminate the pathogen before it causes noticeable disease symptoms.1

    image18.jpg

    Figure 16 | Activation of a T cell | 19 Upon recognizing an antigen fragment presented on an MHC molecule, naïve T cells become activated. This interaction can trigger clonal expansion and differentiation into effector subsets, including cytotoxic T cells (CD8⁺) or helper T cells (CD4⁺) depending on the MHC class involved.

    image13.jpg

    Figure 17 | Helper T cell Activation and Effector Functions | 20 Activation of a naïve T cell by antigen-MHC recognition triggers clonal expansion, producing a population of T cells with identical antigen specificity. Effector T cells carry out immune responses against infected target cells, while a subset differentiates into long-lived memory T cells for rapid response upon re-exposure.

    image4.jpg

    Figure 18 | Clonal Selection and Expansion of T Lymphocytes | 21 (a) Helper T cells secrete cytokines that support and regulate the adaptive immune response. (b) Cytotoxic T cells directly eliminate infected cells by releasing perforin and granzymes, inducing target cell apoptosis.

    image25.jpg

    Figure 19 | Effector function of Cytotoxic T cell | 22  Cytotoxic T cells bind infected cells and release granules to induce apoptosis.

    Overview of Cell-Mediated Immunity

    Cell-mediated immunity begins with antigen presentation, where APCs such as dendritic cells engulf and process pathogens, displaying their fragments on MHC molecules. Naïve T cells, specifically CD4+ helper T cells and CD8+ cytotoxic T cells, recognize these antigen-MHC complexes, with CD4+ cells binding to MHC class II and CD8+ cells to MHC class I. Upon activation, CD4+ T cells release cytokines that enhance immune responses, stimulating macrophages, B cells, and cytotoxic T cells. Cytotoxic T cell activation requires not only antigen recognition but also costimulation in the form of cytokines released by the activated helper T cells. Activated CD8+ T cells differentiate into effectors that directly attack infected cells, inducing apoptosis. A small population of T cells become memory cells, allowing for rapid responses upon re-exposure to pathogens (Figures 16 -19). Once the infection is controlled, most effector T cells undergo apoptosis, while memory T cells persist, ensuring long-term immunity.

    Antibody-Mediated Immunity and B Lymphocytes

    Antibody-mediated immunity, or humoral immunity, is crucial for protecting the host against extracellular and exogenous antigens, including bacterial toxins, polysaccharide capsules, viral infections, and certain malignant cells. This immune response is primarily driven by B lymphocytes, which produce antibodies—soluble forms of B cell receptors. While naïve B cells express surface antibodies, plasma cells secrete antibodies with the same antigen-binding specificity. Humans have five major antibody classes (IgM, IgD, IgG, IgA, and IgE), each with distinct roles. Unlike T cells, B cells can directly recognize native antigens without relying on MHC molecules or APCs, enabling them to effectively respond to a diverse range of pathogens.

    B Cell Differentiation 

    B cells undergo their differentiation process within the bone marrow, and this journey leads to the generation of an astonishing diversity of up to 100 trillion different B cell clones. This diversity closely parallels the immense range of antigen receptors observed in T cells. While B cell differentiation and tolerance development mechanisms are not as fully elucidated as in T cells, certain critical aspects are well established. Central tolerance, for instance, plays a pivotal role. It involves the destruction or inactivation of B cells recognizing self-antigens within the bone marrow. Central tolerance includes clonal deletion, where immature B cells strongly binding to self-antigens undergo apoptosis, eliminating them from the B cell population. Additionally, clonal anergy is another mechanism, rendering B cells exposed to soluble antigens in the bone marrow unable to function. Peripheral tolerance, on the other hand, arises partly from T cell tolerance. Here, mature B cells exit the bone marrow without encountering self-antigens. Most protein antigens necessitate signals from helper T cells to initiate antibody production. When a B cell binds to a self-antigen but does not receive signals from a nearby helper T cell, it is prompted to undergo apoptosis. It is subsequently eliminated, which exemplifies the regulatory influence exerted by T cells on the adaptive immune response.

    Upon activation by antigen binding, B cells differentiate into plasma cells. Plasma cells often migrate from secondary lymphoid organs, where the immune response originates, back to their place of origin—the bone marrow. After a specific period of secreting antibodies, these plasma cells undergo apoptosis, as their primary focus is antibody production. Memory B cells arise from activated B cells and play a crucial role in generating a quicker and more robust secondary immune response, enhancing overall immune defense. 

    Antibody Structure

    Antibodies are crucial glycoproteins in the immune system, composed of two distinct polypeptide chains—heavy chains and light chains—along with carbohydrate groups. Each antibody consists of two identical heavy chains and two identical light chains, forming a four-chain structure that varies primarily in the heavy chains, though the light chains also contribute to the antigen-binding region. The Fc region, formed by the heavy chains, interacts with Fc receptors on immune effector cells, enhancing the immune response (Figure 20). At the opposite end, two identical antigen-binding sites recognize specific antigens.1

    image8.jpg

    Figure 20 | The Structure of an Antibody | 23 Antibodies are quaternary proteins made up of two light chains and two heavy chains. The antigen-binding site is located in the variable domain, formed by the interaction between the light and heavy chains. The constant region, composed only of heavy chains, is responsible for the antibody’s effector functions.

    B cell and T cell receptors are essential to the adaptive immune system, each serving unique functions in pathogen recognition. B cell receptors, which are surface-bound immunoglobulins on B cells, can directly bind to free antigens or those on pathogens, recognizing extracellular antigens such as the three-dimensional structures of proteins, lipids, carbohydrates, and nucleic acids, leading to antibody production. In contrast, T cell receptors, located on T cells, recognize processed intracellular antigens presented by APCs as linear peptide structures through MHCs (Table 7).

    Table 7 | Comparison of B and T Cell Receptors |
    B Cell Receptor T Cell Receptor
    Membrane bound antibodies Membrane bound
    Recognize extracellular antigens: 3D structures of proteins, lipids, carbohydrates, and nucleic acids Recognize intracellular antigens: linear structures of peptides
    Recognizes antigen (MHC molecule is not required) Must recognize both antigen and the MHC molecule (cell-associated)

    Isotype Switching

    image12.jpg

    Figure 21 | Isotype Switching | 24 Heavy chain genes are separated by short tandem repeats which are recognized by specific enzymes. In response to cytokine signals, these enzymes excise portions of the DNA, allowing the B cell to produce antibodies with different constant regions and effector functions.

    Isotype switching, also known as class switching, is a crucial process in the adaptive immune response that allows B cells to produce different classes of antibodies while retaining the same antigen specificity. This occurs after initial activation when a B cell engages with an antigen and receives signals from helper T cells. During isotype switching, the constant region of the antibody heavy chain is altered while keeping the same antigen-binding variable region in both heavy and light chains, enabling the production of various antibody isotypes, such as IgM, IgG, IgA, or IgE. 

    Isotype switching involves a series of steps following the activation of B cells, primarily occurring in the germinal centers of lymphoid tissues. Initially, a naïve B cell recognizes an antigen and becomes activated, often with the help of helper T cells. Prior to isotype switching, B cells undergo VDJ recombination, where variable (V), diversity (D), and joining (J) gene segments are rearranged to create the variable region of the antibody. After activation, cytokine signaling from helper T cells directs the specific isotype to be produced, such as IgG or IgA. The process of switch recombination then takes place, which rearranges the heavy chain constant region gene segments, allowing the selected constant region to pair with the existing variable region (Figure 21). As a result, the B cell produces the new antibody isotype while retaining the same antigen specificity, enabling a tailored immune response to different pathogens.25

    Classification of Antibodies and their Functions

    Antibodies serve two primary functions within the immune system. Firstly, they can serve as the B cell antigen receptor, enabling B cells to recognize specific antigens. Secondly, antibodies can be secreted, circulating within the body, and binding to pathogens, often marking them for recognition by other immune response elements. Among the five antibody classes, only two can function as antigen receptors for naïve B cells, namely IgM and IgD (Figure 22). Mature B cells express both IgM and IgD on their surface, with both types of antibodies possessing identical antigen specificity. However, only IgM is secreted, and no additional nonreceptor role has been ascribed to IgD.

    IgM is composed of five four-chain structures (comprising a total of 20 chains with ten identical antigen-binding sites) and stands as the largest among antibody molecules. It is the initial antibody produced during a primary immune response. Its substantial size and ten antigen-binding sites facilitate effective binding to various bacterial surfaces. IgM excels in interacting with complement proteins and initiating the complement cascade, consistent with its pivotal role in enhancing chemotaxis, opsonization, and cell lysis. Consequently, IgM proves highly efficient in combating bacterial threats during the early stages of a primary antibody response. As the primary response progresses, antibodies generated within B cells can undergo class switching, permitting transformation into IgG, IgA, or IgE. Class switching denotes transitioning from one antibody class to another while retaining the same specificity and antigen-binding sites. Hence, the resulting antibodies remain specific to the pathogen that initially triggered the IgM response.

    IgG, a monomeric antibody, plays a prominent role in late primary immune responses and serves as the predominant antibody during secondary responses within the bloodstream. This dominance results from class switching taking place during primary responses. IgG is a crucial agent in clearing pathogens from the bloodstream and can activate complement proteins, albeit less efficiently than IgM. These attributes make IgG effective in combating extracellular pathogens as it can exit the bloodstream and enter the interstitial fluid.

    IgA is present in two forms: a four-chain monomer found in the blood and an eight-chain structure, known as a dimer, located in exocrine gland secretions of mucous membranes, including mucus, saliva, and tears. As the sole antibody capable of exiting the body's interior, the dimeric IgA safeguards body surfaces. Notably, IgA assumes significant importance in newborns, as it is present in maternal breast milk (colostrum), providing defense against infections to the nursing infant.

    IgE is primarily recognized for its association with allergic reactions and anaphylactic responses. It is found in the bloodstream at the lowest concentrations among all antibody classes due to its distinct interaction with an IgE-specific Fc receptor situated on the surfaces of mast cells. This interaction imparts an extraordinary specificity to mast cell degranulation. For instance, peanut-specific IgE antibodies will be affixed to their mast cells if an individual has an allergy to peanuts. In such cases, consumption of peanuts triggers mast cell degranulation, often leading to severe allergic manifestations, including anaphylaxis—an intense, systemic allergic reaction with potentially life-threatening consequences.1, 25

    image20.jpg

    Figure 22 | Classification of Antibodies | 26 This figure compares the functional and structural differences in the five major antibody classes—IgM, IgG, IgA, IgE, and IgD— of the immune system.

    Activation of B Lymphocytes

    For the B cell to become activated, it must receive two distinct signals. First, its surface immunoglobulin must recognize the native antigen, some of which is internalized, processed, and then presented to Th2 cells via class II MHC molecules (Figure 23). Subsequently, the T cell binds to this presentation through its antigen receptor, activating cytokines that diffuse towards the B cell, ultimately completing the activation process. Consequently, the B cell receives signals from both its surface antibody and the T cell via its cytokines, effectively functioning as a professional antigen-presenting cell during this intricate process.

    image9.jpg

    Figure 23 | Activation of B Cell | 27 Activation of B cells begins with the binding of the MHC II receptor on the B cell to the CD4+ receptor on the T helper cell. This interaction triggers the release of cytokines by the T cell, which stimulate B cell activation.

    Key players in antibody-mediated immunity include B cells, dendritic cells, and macrophages, which capture and process antigens from pathogens. These antigen fragments are linked with class II MHC proteins, forming an antigen-MHC II complex that is displayed on the surface of APCs to attract helper T cells. When helper T cells bind to these complexes on dendritic cells or macrophages, they become activated, releasing cytokines that drive the differentiation of naïve helper T (Th0) cells into Th2 cells (Figure 23). These Th2 cells, critical to humoral immunity, engage with B cells through T cell receptor/antigen-MHC II interactions, guiding them to respond to the antigen. Although B cells can recognize antigens with their surface antibodies, they require additional cytokine stimulation from helper T cells. This costimulation triggers B cells to proliferate and differentiate into antibody-secreting plasma cells and memory B cells (Figure 24). Cytokines such as IL-4, IL-6, and IL-10 released by Th2 cells, along with IL-6 from B cells, play a vital role in coordinating this immune response, strengthening the body’s defenses against pathogens.

    Clonal Selection of B Cells

    Clonal selection and expansion in B cells closely resemble the process in T cells, where specific B cells are selected to proliferate, as shown in Figure 24. The outcome is the production of plasma cells that secrete antibodies matching the antigenic specificity of the originally selected B cells. During this process, both plasma cells and memory B cells are generated simultaneously, allowing for immediate antibody production and long-term immune memory.1, 25

    image10.jpg

    Figure 24 | Clonal Selection of B Cells | 28  This figure illustrates the clonal expansion of B cells during an immune response. Upon activation, B cells differentiate into two major populations: antibody producing plasma cells and memory B cells. Memory B cells remain in the body after the infection and are primed to respond more efficiently upon re-exposure to the same pathogen, facilitating a faster and stronger secondary immune response.

    Roles of Antibodies in Immune Defense

    Plasma cells produce large quantities of antibodies that target specific pathogens through several mechanisms. First, antibodies neutralize pathogens by binding to them and blocking their entry into host cells. They also enhance phagocytosis through opsonization, marking pathogens so phagocytes can easily recognize and engulf them (Figure 25). In addition, some antibodies activate the complement system, which triggers pathogen lysis and inflammation, further enhancing the immune response. Antibodies can also agglutinate pathogens, causing them to clump together, making it easier for immune cells to capture and remove them. Another important mechanism is antibody-dependent cellular cytotoxicity, in which antibodies recruit natural killer cells and other immune cells to destroy infected cells directly. Through these mechanisms, antibodies play a comprehensive role in eliminating infections, while memory B cells provide rapid, robust responses if the pathogen is encountered again.

    image26.jpg

    Figure 25 | Roles of Antibodies in Immune Defense | 29 Antibodies defend against pathogens through several mechanisms (1) Antibodies can opsonize the cell surface of pathogens, enhancing phagocytosis by immune cells. (2) In agglutination, antibodies cause pathogens to clump together, facilitating their clearance. (3) Antibodies can bind to pathogens or toxins and neutralize the harmful effects. (4) Antibodies can activate the complement system to promote inflammation, phagocytosis, and direct pathogen destruction.

    The classical pathway of complement activation begins when antibodies, typically IgG or IgM, bind to antigens on a pathogen’s surface. This antibody-antigen interaction allows the complement system to recognize the pathogen, triggering a cascade of reactions. Key proteins in this cascade cleave other complement proteins, leading to the formation of C3 convertase, which splits C3 into C3a and C3b. C3b attaches to the pathogen, tagging it for phagocytosis (opsonization) and forming C5 convertase. This enzyme initiates the assembly of the MAC, which punctures the pathogen’s membrane, causing cell lysis. Additionally, C3a and C5a enhance inflammation, further supporting immune cell recruitment and pathogen clearance (Figure 11).

    Primary versus Secondary Responses

    The first encounter between the immune system and a pathogen is termed the primary response. This response tends to be severe as the adaptive immune system takes time to mount an effective defense. In contrast, upon re-exposure to the same pathogen, the secondary response occurs, characterized by enhanced speed and strength, often neutralizing the pathogen before it can cause significant damage or symptoms. This rapid response is the basis of immunological memory, which provides lasting protection against recurrent infections. 

    Primary and secondary immune responses, as they pertain to B cells and antibody production, are essential components of the immune system's defense against pathogens. Antibodies, being easily detectable in blood samples, clearly illustrate these responses (Figure 26). In the primary response, which occurs upon initial exposure to an antigen representing a pathogen, there is a notable delay of several days. During this time, B cell clones undergo expansion and differentiation, ultimately producing plasma cells. While the production of antibodies is relatively low during this phase, it is sufficient for providing a degree of immune protection. There is no such time delay upon encountering the same antigen for a second time. Instead, the immune system mounts a rapid and robust secondary antibody response. This results in a significantly higher quantity of antibodies being produced. Consequently, the secondary immune response effectively overwhelms the pathogens, often without the individual experiencing noticeable symptoms. Each new encounter triggers another primary response in cases involving different antigens, characterized by lower antibody levels and a time delay before reaching peak effectiveness.

    image3.jpg

    Figure 26 | Primary and Secondary Antibody Responses | 30 Antigen A is given once to generate a primary response and later to generate a secondary response. When a different antigen is given for the first time, a new primary response is made.

    Active Versus Passive Immunity

    Immunity against pathogens, essential for preventing tissue damage, is achieved through either *active* or *passive* approaches. Active immunity involves an individual's own adaptive immune response, providing resistance to infections naturally through exposure to pathogens or artificially via vaccines. Vaccines, made of killed or weakened pathogens, trigger a controlled immune response that builds immunological memory without causing significant illness, offering future protection. The advent of vaccines has led to groundbreaking control of diseases like smallpox, polio, and measles, highlighting their importance in public health.

    Table 11 | Active versus Passive Immunity |
      Nature Artificial
    Active Adaptive immune response Vaccine response
    Passive Trans-placental antibodies/breastfeeding Immune globulin injections

    Natural and Acquired Immunity

    Passive immunity is achieved by transferring antibodies to an individual, allowing them to gain immunity without initiating their own active response. Naturally acquired passive immunity occurs during fetal development when IgG antibodies cross the placenta, offering the fetus and newborn temporary protection against infections. Breastfeeding extends this protection as IgA antibodies in breast milk support the newborn's immune defenses. In medical settings, artificially acquired passive immunity is provided by administering antibodies from previously exposed animals, offering rapid but temporary protection without fostering immunological memory, as transferred antibodies degrade over time.

     


    14.7: The Adaptive Immune Response is shared under a CC BY-NC-SA license and was authored, remixed, and/or curated by LibreTexts.